Evidence map›Paper›PMID 34315897›Full record

ArticleNature communications2021

The apicoplast link to fever-survival and artemisinin-resistance in the malaria parasite.

Min Zhang, Chengqi Wang, Jenna Oberstaller, Phaedra Thomas, Thomas D Otto, Debora Casandra, Sandhya Boyapalle, Swamy R Adapa, Shulin Xu, Katrina Button-Simons and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. mSphere · 2026
    Article
  3. Article
  4. A Multidimensional Analysis of the Bimodal Piperaquine Response inbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Integrative genomics ofbioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Article
  10. Evolutionary Trajectory ofBiomedicines · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. The essential genome ofScience (New York, N.Y.) · 2025
    Article
  15. Article
  16. Article
  17. Artemisinin-resistant malaria.Clinical microbiology reviews · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Min Zhang *Center for Global Health and Infectious Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, Tampa, FL, USA.ORCID 0000-0002-5443-0992
Chengqi Wang *Center for Global Health and Infectious Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, Tampa, FL, USA.
Jenna Oberstaller *Center for Global Health and Infectious Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, Tampa, FL, USA.ORCID 0000-0002-3033-2212
Phaedra ThomasCenter for Global Health and Infectious Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, Tampa, FL, USA.ORCID 0000-0003-3861-1213
Thomas D OttoWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.
Debora CasandraCenter for Global Health and Infectious Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, Tampa, FL, USA.
Sandhya BoyapalleCenter for Global Health and Infectious Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, Tampa, FL, USA.
Swamy R AdapaCenter for Global Health and Infectious Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, Tampa, FL, USA.
Shulin XuCenter for Global Health and Infectious Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, Tampa, FL, USA.
Katrina Button-SimonsEck Institute for Global Health, Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA.ORCID 0000-0001-5248-7939
Matthew MayhoWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.
Julian C RaynerWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.ORCID 0000-0002-9835-1014
Michael T FerdigCambridge Institute for Medical Research, University of Cambridge, Cambridge Biomedical Campus, Cambridge, Cambridgeshire, UK.
Rays H Y JiangCenter for Global Health and Infectious Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, Tampa, FL, USA.
John H AdamsCenter for Global Health and Infectious Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, Tampa, FL, USA. ja2@usf.edu.ORCID 0000-0003-3707-7979
University of South Florida · USUniversity of Cambridge · GBWellcome Sanger Institute · GBUniversity of Notre Dame · US

Funding

Chemogenomic Profiling of Plasmodium Falciparum Responses and ResistanceR01AI117017 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI ADAMS, JOHN H · 2015 to 2025
$6.9M
A large-scale transposon mutagenesis screen of Plasmodium falciparumR01AI094973 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI ADAMS, JOHN H · 2011 to 2015
$1.8M
Post-transcriptional regulation in the malaria parasite blood stageF32AI112271 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI OBERSTALLER, JENNA · 2015 to 2017
$173k
Functional characterization of a conserved phosphatase of Plasmodium falciparumF31AI083053 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI CAMPBELL, CHRISTOPHER O · 2009 to 2010
$60k
NIAID NIH HHS F32 AI112271NIAID NIH HHS R01 AI094973NIAID NIH HHS R01 AI117017Wellcome Trust 098051
6 · The paper itself

Abstract

The emergence and spread of Plasmodium falciparum parasites resistant to front-line antimalarial artemisinin-combination therapies (ACT) threatens to erase the considerable gains against the disease of the last decade. Here, we develop a large-scale phenotypic screening pipeline and use it to carry out a large-scale forward-genetic phenotype screen in P. falciparum to identify genes allowing parasites to survive febrile temperatures. Screening identifies more than 200 P. falciparum mutants with differential responses to increased temperature. These mutants are more likely to be sensitive to artemisinin derivatives as well as to heightened oxidative stress. Major processes critical for P. falciparum tolerance to febrile temperatures and artemisinin include highly essential, conserved pathways associated with protein-folding, heat shock and proteasome-mediated degradation, and unexpectedly, isoprenoid biosynthesis, which originated from the ancestral genome of the parasite's algal endosymbiont-derived plastid, the apicoplast. Apicoplast-targeted genes in general are upregulated in response to heat shock, as are other Plasmodium genes with orthologs in plant and algal genomes. Plasmodium falciparum parasites appear to exploit their innate febrile-response mechanisms to mediate resistance to artemisinin. Both responses depend on endosymbiont-derived genes in the parasite's genome, suggesting a link to the evolutionary origins of Plasmodium parasites in free-living ancestors.

Indexed as

Drug ResistanceAnimalsApicoplastsArtemisininsFeverGene Expression RegulationHeat-Shock ResponseMalaria, FalciparumMutationParasitesPhenotypePlasmodium falciparumSignal TransductionTemperatureTerpenesTranscription, GeneticartemisininArtemisininsTerpenes

Identifiers

PMID34315897
PMCPMC8316339
OpenAlexW3184062432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.